| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT03900793 Losartan + Sunitinib in Treatment of Osteosarcoma |
date change Primary completion pushed: 2026-08 -> 2027-08-01 |
| 2026-06-12 | NCT03900793 Losartan + Sunitinib in Treatment of Osteosarcoma |
date change Completion pushed: 2027-02 -> 2029-08-01 |
| 2026-05-30 | NCT02693535 TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a… |
Trial sites expanded: 174 -> 181 locations |
| 2026-05-28 | NCT07218926 A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With… |
Trial sites expanded: 84 -> 121 locations |
| 2026-05-23 | NCT05208047 (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With… |
Trial arms changed: 6 -> 7 |
| 2026-05-23 | NCT05208047 (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With… |
date change Completion pushed: 2026-09 -> 2030-01 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05477576 | Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET… | GEP-NET | Recruiting |
| NCT07218926 | A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With… | Gastrointestinal Neoplasms | Recruiting |
| NCT03673501 | A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib | Gastrointestinal Stromal Tumors | Active, Not Recruiting |
| NCT02811861 | Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of… | Renal Cell Carcinoma | Active, Not Recruiting |
| NCT03091192 | Savolitinib vs. Sunitinib in MET-driven PRCC. | Carcinoma | Active, Not Recruiting |
| NCT03768063 | A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd… | Cancer | Active, Not Recruiting |
| NCT05043090 | Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven… | Papillary Renal Cell Carcinoma | Active, Not Recruiting |
| NCT05208047 | (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With… | Advanced Gastrointestinal Stromal Tumors | Active, Not Recruiting |
| Phase 2 | |||
| NCT07477457 | A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard… | Osteosarcoma | Recruiting |
| NCT03297606 | Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) | Lymphoma, Non-Hodgkin | Recruiting |
| NCT02693535 | TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a… | Lymphoma, Non-Hodgkin | Recruiting |
| NCT03899155 | Pan Tumor Rollover Study | Cancer | Recruiting |
| NCT05773274 | Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With… | Metastatic Digestive System Neuroendocrine Tumor G1 | Recruiting |
| NCT00329043 | Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy | Prostate Cancer | Active, Not Recruiting |
| NCT03541902 | Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant… | Malignant Neoplasms of Urinary Tract | Active, Not Recruiting |
| NCT02068586 | Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk… | Ciliary Body and Choroid Melanoma, Medium/Large Size | Active, Not Recruiting |
| NCT03463460 | Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or… | Thymic Carcinoma | Active, Not Recruiting |
| NCT01396408 | A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours | Advanced Rare Tumours | Active, Not Recruiting |
| NCT06390826 | Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes… | Advanced Lymphoma | Active, Not Recruiting |
| NCT02465060 | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced… | Advanced Lymphoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT05024214 | Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors | Solid Tumors | Recruiting |
| Phase 1 | |||
| NCT05687123 | Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in… | Metastatic Pancreatic Neuroendocrine Tumor | Recruiting |
| NCT03900793 | Losartan + Sunitinib in Treatment of Osteosarcoma | Osteosarcoma | Recruiting |
| NCT05245968 | A Study of Pimitespib in Combination With Imatinib in Patients With GIST… | Gastrointestinal Stromal Tumors | Active, Not Recruiting |